Vancouver-based company SaNOtize, co-founded by Israeli-Canadian scientist Dr Gilly Regev, launched its first clinical trial in the UK, Monday, 18 January, a proposed antiviral nasal spray for use against COVID-19.
Read more here.
Vancouver-based company SaNOtize, co-founded by Israeli-Canadian scientist Dr Gilly Regev, launched its first clinical trial in the UK, Monday, 18 January, a proposed antiviral nasal spray for use against COVID-19.
Read more here.
![[MUV Interactive in Tech Times] MUV Interactive and Silicon Technology launch BIRD wearable in Japan](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
